We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTR icon
901
Ventas
VTR
$47.2B
$217K 0.02%
3,100
-14,662
-83% -$985K
EOLS icon
902
Evolus
EOLS
$500M
$217K 0.02%
+35,267
New +$275K
IEI icon
903
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$216K 0.02%
+1,810
New +$215K
ELP
904
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$216K 0.02%
22,000
-16,000
-42% -$144K
DXCM icon
905
DexCom
DXCM
$33.1B
$216K 0.02%
+3,204
New +$254K
NTAP icon
906
NetApp
NTAP
$39B
$216K 0.02%
+1,820
New +$204K
EVER icon
907
EverQuote
EVER
$900M
$215K 0.02%
+9,411
New +$227K
AQST icon
908
Aquestive Therapeutics
AQST
$538M
$215K 0.02%
38,473
-26,229
-41% -$113K
IDR icon
909
Idaho Strategic Resources
IDR
$560M
$215K 0.02%
+6,360
New +$150K
KBR icon
910
KBR
KBR
$4.83B
$215K 0.02%
4,540
-8,705
-66% -$422K
RTAC
911
Renatus Tactical Acquisition Corp I
RTAC
$326M
$213K 0.02%
+19,562
New +$220K
OBE
912
Obsidian Energy
OBE
$699M
$213K 0.02%
32,562
-19,790
-38% -$118K
AU icon
913
AngloGold Ashanti
AU
$49.2B
$212K 0.02%
+3,021
New +$169K
AVTR icon
914
Avantor
AVTR
$9.29B
$212K 0.02%
+17,000
New +$219K
NTB icon
915
Bank of N.T. Butterfield & Son
NTB
$2.46B
$212K 0.02%
+4,939
New +$223K
HLF icon
916
Herbalife
HLF
$1.21B
$211K 0.02%
25,059
-24,966
-50% -$235K
IVZ icon
917
Invesco
IVZ
$14B
$211K 0.02%
9,203
-3,931
-30% -$81.6K
BFLY icon
918
Butterfly Network
BFLY
$2.58B
$211K 0.02%
+109,374
New +$186K
LCII icon
919
LCI Industries
LCII
$2.55B
$211K 0.02%
+2,262
New +$226K
CXM icon
920
Sprinklr
CXM
$1.62B
$211K 0.02%
27,274
+16,674
+157% +$141K
BOX icon
921
Box
BOX
$4.65B
$210K 0.02%
+6,523
New +$211K
TSLA icon
922
CALL
Tesla
TSLA
$1.31T
$210K 0.02%
+120
New +$41.6K
HOLX
923
DELISTED
Hologic
HOLX
$210K 0.02%
+3,113
New +$207K
VCIC
924
DELISTED
Vine Hill Capital Investment Corp
VCIC
$210K 0.02%
+19,562
New +$206K
CIB icon
925
Grupo Cibest SA
CIB
$21.7B
$208K 0.02%
4,000
-8,250
-67% -$398K
35 36
37
38 39

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.